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Abstract
A new family of nanoscale materials on the basis of dispersed networks of cross-linked ionic and nonionic hydrophilic
polymers is being developed. One example is the nanosized cationic network of cross-linked poly(ethylene oxide) (PEO) and
polyethyleneimine (PEI), PEO-cl-PEI nanogel. Interaction of anionic amphiphilic molecules or oligonucleotides with
PEO-cl-PEI results in formation of nanocomposite materials in which the hydrophobic regions from polyion-complexes are
joined by the hydrophilic PEO chains. Formation of polyion-complexes leads to the collapse of the dispersed gel particles.
However, the complexes form stable aqueous dispersions due to the stabilizing effect of the PEO chain. These systems allow
for immobilization of negatively charged biologically active compounds such as retinoic acid, indomethacin and
oligonucleotides (bound to polycation chains) or hydrophobic molecules (incorporated into nonpolar regions of polyion–
surfactant complexes). The nanogel particles carrying biological active compounds have been modified with polypeptide
ligands to enhance receptor-mediated delivery. Efficient cellular uptake and intracellular release of oligonucleotides
immobilized in PEO-cl-PEI nanogel have been demonstrated. Antisense activity of an oligonucleotide in a cell model was
elevated as a result of formulation of oligonucleotide with the nanogel. This delivery system has a potential of enhancing
oral and brain bioavailability of oligonucleotides as demonstrated using polarized epithelial and brain microvessel
endothelial cell monolayers. Ó 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction persed hydrogels is simple, results in relatively high
drug loading capacity and may provide advantage
Polymeric drug carriers of nanoscale size range from regulatory prospective because polymer gels
have attracted increasing attention in recent years are synthesized and evaluated in the absence of the
[1–5]. Polymers of synthetic and natural origin were drug. This paper overviews the preparation and use
used for preparation of such drug delivery systems. of nanoscale hydrogels for drug delivery. For sim-
1For example, biodegradable polyester nanoparticles plicity these systems will be called ‘the nanogels’.
are well-known carriers for low molecular mass Along with this term we will be using the term
drugs, oligonucleotides and peptides [2]. The advan- ‘microgels’ to define gel particles of the micron scale
tages of using nanoparticles for drug delivery result size range.
from their two basic properties. First, nanoparticles, Many of the examples of the pharmaceutical use
due to their small size, penetrate within even small of dispersed hydrogels that are discussed in this
capillaries and are taken up within cells, which paper were obtained using nanogels from cross-
allows for efficient drug accumulation at the target linked poly(ethylene oxide) (PEO) and poly-
sites in the body [6–8]. Second, the use of bio- ethyleneimine (PEI). This system represents a spe-
degradable materials for nanoparticle preparation cial type of a dispersed copolymer network in which
allows for sustained drug release within the target cationic chains (PEI) alternate with hydrophilic
site over a period of days or even weeks after nonionic chains (PEO). As a result of the double
injection [9]. These advantages come at the substan- functionality, this system, called PEO-cl-PEI
tial cost of a relatively low drug loading capacity and nanogel, exhibits combined properties of a swollen
relatively complicated preparation procedure, which polyelectrolyte network and a hydrophilic nonionic
requires presence of the drug in the reaction mixture network. Polyelectrolyte chains exhibit the ability to
and often leads to the drug inactivation. bind oppositely charged counterions or macromole-
An alternative approach is to use swollen hydro- cules, leading to the collapse of the gel, while,
philic polymer gels of nanoscale size that can be hydrophilic nonionic chains prevent precipitation and
synthesized in the absence of the drug and then stabilize the particles in aqueous dispersions. PEO-
loaded with the drug resulting in a gel collapse and cl-PEI nanogels were reacted with a variety of
formation of nanoparticles [10–12]. Drug loading is materials including anionic surfactants and polynu-
usually achieved through self-assembly mechanisms cleotides. Furthermore, substantial amount of data is
involving noncovalent interactions between the drug now available regarding interaction of these materi-
and the polymer matrix, such as electrostatic interac- als with cells. This justifies the primary focus on the
tions, hydrogen bond formation and hydrophobic PEO-cl-PEI nanogels in the present review. Some
interactions. Additionally, drug molecules can be other examples of dispersed networks from alternat-
immobilized in the polymer gels via formation of a
1cleavable covalent bond between the drug moiety NanogelE is a registered trademark of Supratek Pharma Inc.
and the polymer matrix. The approach using dis- (Montreal, Canada).
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ing ionic and nonionic chains, particularly, poly- process towards macrogelation is constrained by the
(methacrylic acid) and PEO, can be also found in maximum size of the emulsion droplets. Structure
literature [13,14]. and properties of microgels depend on composition
and concentration of the monomers at the reaction
sites, reactivity ratios, and solubility of the co-mono-
2. Dispersed hydrogel networks mers in water. Diffusion control of the copoly-
merization rate is favored by (i) cross-linking, (ii)
A gel is a three-dimensional cross-linked polymer high concentration of the oil-soluble initiator and of
network immersed in a fluid. Dispersed gel particles, the emulsifier, and (iii) low solubility of the
microgels and nanogels, can be viewed as cross- comonomer in water [24]. One of the reactive
linked latex particles, which are swollen by a good components in the emulsion copolymerization can be
solvent. If the good solvent is water these species used as an emulsifier. For example, the microgel
belong to a hydrogel class. Colloidal stability of such particles of unsaturated polyester and styrene were
systems results primarily from matching of the prepared by cross-linking self-emulsifying copoly-
Hamaker constants of the swollen particles and the merization using unsaturated polyester with terminal
solvent. These systems are currently being actively carboxylic acid groups (1,6-hexanediol-maleic an-
investigated due to their potential technological hydride copolymer). In this process the polyester
applications in a large number of areas: medicine, served as both the reactive component and emulsifier
industry, and environmental cleanup. Applications of for the styrene monomer. It was shown that the size
such materials include surface coating [15–17], of the gel particles obtained by this method varied
uptake and release of heavy metal ions [18,19], drug from 20 nm to 300 nm and strongly depended on the
delivery [20,21], optoelectronic switches [22], and ratio between the components [25,26]. Microgels can
others. The research in these fields is propelled by be synthesized also by surfactant-free emulsion
the interest in the ability of hydrogel materials to copolymerization, employing sonication instead of a
respond reversibly to external stimuli, such as tem- conventional stirring technique [27]. By adjusting the
perature, pH, ionic strength, solvent nature, and ionic strength, initiator concentration and polymeri-
external stress. The microgel and nanogel particles zation temperature, monodisperse polystyrene latexes
are of particular interest because they exhibit intrin- with particle sizes 0.1–1.0 mm were prepared by
sic properties of gels combined with the properties of single-stage radical polymerization in the absence of
colloids, such as microheterogeneous structure, small surfactants [28,29]. In this case the total initial ionic
size and high surface to volume ratio. strength determined the particle size in the latexes.
Monodisperse, cationic microgels from 2-vin-
ylpyridine [30] or from the copolymer of 2-vin-
3. Synthesis of dispersed networks ylpyridine and styrene were synthesized using a
cationic initiator 2,29-azobis(2-amidinopropane)
3.1. General overview of microgel and nanogel dihydrochloride [31]. Various anionic microgel par-
synthesis procedures ticles were prepared by polymerizing a monomer
mixture containing carboxylic acid monomers and
Various approaches can be used for preparation of vinyl monomers [16,18,32–34]. It was recently
both bulk (macrogels) and dispersed gels. Macrogels shown that the microgels and nanogels can be
in general are prepared using quiescent solutions in obtained by addition or step-growth polymerization
the presence of cross-linker and an accelerator. The of the polyfunctional monomers in solution [35]. A
products tend to be homogeneous with respect to wide range of cross-linking systems and solvents
composition. Microgel particles are usually synthes- were evaluated using this approach. To avoid mac-
ized by emulsion polymerization or copolymerization rogelation the polyfunctional precursors should be
at elevated temperature using rapidly stirred solu- used below their critical gelation concentration, and
tions in order to obtain stable dispersions [23]. In the solvent solubility parameters should be carefully
this case the progression of the polymerization chosen for each polymer type made. It was hypoth-
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esized that the gels prepared using this technique activated PEO proceeded very rapidly resulting in
contain (i) ‘dead’ chains, (ii) polymerizing chains, formation of transparent hydrogels in only 3–5 min.
and (iii) chain loops, which all can act as effective These bulk hydrogels retained large quantities of
steric stabilizers in a good solvent. These chains water reaching approximately 50-fold by weight
prevent particle-particle cross-linking and macrogela- compared to the dried substance. Rigid hydrogels
tion resulting in formation of gel dispersion. could be produced at the minimal PEO/PEI molar
Polymeric gels containing several distinct types of ratio 6 or higher. To obtain fine dispersed systems,
chain fragments can be synthesized by polymeri- the cross-linking reaction was performed by a modi-
zation of the monomer that forms one of the network fied solvent emulsification /evaporation method [40].
fragments in the presence of another fragment(s). For According to this method, activated PEO solution in
example, polymerizing epoxides with poly- dichloromethane was emulsified in the aqueous
alkylenepolyamines produced polymer beads [36]. solution of PEI by sonication (Fig. 1). The organic
Cationic microgel dispersions were produced by solvent was removed from the mixture in vacuo
cross-linking polyepoxide-amine reaction products resulting in formation of a clear suspension. This
with polyepoxide cross-linking agent [15]. The nano- suspension was centrifuged to remove debris and
sized poly(methacrylic acid-g-ethylene glycol) gels large particles. Most of the nanogel particles had a
were prepared by micellar polymerization of very low density and could not be fractionated by
methacrylic acid in the presence of poly(ethylene ultracentrifugation. Therefore, crude suspension of
glycol) monomethyl ether monomethacrylate [37]. nanogel particles was purified using gel-permeation
Another approach to synthesizing polymer networks chromatography. Several fractions could be sepa-
involves cross-linking of pre-formed polymer frag- rated by particle size from 300 to 40 nm, with a
ments. For example, cross-linked polymer gels or major fraction (ca. 70% of the product) having
films were prepared by cross-linking homopolymers average particle diameter between 150 and 240 nm.
and copolymers of acrylamide, N-substituted acryl- The quantity of PEO and PEI components in these
1
amide or N-substituted methacrylamide with poly- nanogel preparations was determined from H-NMR
amines or polyols [38]. The microgel particles were spectra the average PEO/PEI ratios ranged from 6 to
obtained by chemically cross-linking of the collapsed 7.
hydroxypropyl cellulose polymer chains in water-
surfactant dispersions [39]. Overall, there are numer-
ous methods of preparation of the microgel particles, 4. Swelling of nanogel particles
which yield the dispersed networks with the desired
characteristics. By varying the conditions of reaction, The aqueous dispersions of the PEO-cl-PEI par-
including the type and dispersity of the media, ticles were prepared by dissolving of lyophilized
addition of surfactants, temperature, and ratio of powder of the copolymer in the deionized water or
reagents the size of the particles can be controlled. buffer solution followed by bath-sonication for 3–4
Many of the examples of the pharmaceutical use of min. It is well recognized that a balance between the
dispersed hydrogels that are discussed in this paper osmotic pressure and the polymer elasticity sets the
were obtained using PEO-cl-PEI nanogels. The physical dimensions of a hydrogel microsphere [41].
synthesis of these materials is considered in greater The osmotic pressure results from the net difference
detail in the next section. in concentration of mobile ions between the interior
of the microgel particle and exterior solution. For
3.2. Synthesis of PEO-cl-PEI nanogels ionic polymer gels fixed charged groups attract
hydrated counterions, which tend to expand the gel,
PEO-cl-PEI nanogels were synthesized by cross- while the conformational entropy elasticity of the
linking of branched PEI (25 kDa) with bis-activated cross-linked polymer chains opposes this expansion.
PEO (8 kDa) molecules [10]. When conducted in a Neutralizing the gel reduces the net ion concentration
homogeneous aqueous solution the reaction between difference (osmotic swelling pressure). This reduc-
amino groups of PEI and imidazolylcarbonyl ends of tion in the number of counterions results in dehydra-
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Fig. 1. Schematic representation of the synthesis of the PEO-cl-PEI nanogel using emulsification–evaporation method: (A) droplets of
dichloromethane (grey color) containing bis-activated PEO (both ends activated by 1,19-carbonyldiimidazole) is dispersed in the bulk
aqueous solution cantaining PEI; (B) reaction between PEO and PEI proceeds on the surface of the o/w emulsion droplets; (C) organic
solvent is evaporated and the nanogel is maturated for 24 h in aqueous dispersion. The insert presents transmission electron micrograph of
mature nanogel particle (staining with uranyl acetate, 1800003, bar 100 nm).
tion of the gel and decrease in the volume to an conditions is mainly due to the effects of the
extent when the excluded volume of the polymer excluded volumes of hydrophilic PEI and PEO
chains limits the further compression. The polyamine chains. The protonation of amino groups upon
segments of PEO-cl-PEI nanogels are weak poly- lowering of pH to 8.5 resulted in the swelling of
bases and the charge density of such networks PEO-cl-PEI particles and increase in the size of the
depends on pH. Furthermore, PEI segments are particles up to ca. 300 nm. However, the particle size
randomly branched, i.e. contain primary, secondary remained practically constant upon further decrease
and tertiary amino groups. As it was estimated by of pH in the range from 8.5 to 4.0. This behavior
potentiometric titration only approximately 60% of was attributed to a relatively high degree of cross-
the total amount of amino groups could be proton- linking of the PEO-cl-PEI network (ca. 1 PEO chain
ated in the range of pH from 10 to 4 [42]. Despite of per 80 units of PEI) that limits the extent of its
the relatively high concentration of fixed charged swelling. From the experimental perspective one of
groups the PEO-cl-PEI nanogels exhibited relatively the advantages to work with gels in nanosize and
little size variation upon changes in pH. At pH 10 submicron range is the fact that they undergo a very
when practically all amino groups of PEI are un- rapid response to changing environmental conditions
charged the nanogel particle size was ca. 260 nm. [33,34]. In contrast, the swelling equilibrium for the
The swelling of PEO-cl-PEI particles under these macrogels requires periods of the order of days [43].
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5. Interaction of nanogels with surfactants in the sign of zeta-potential can be attributed to
incorporation of the excess of the surfactant into the
Interaction between polyions and oppositely PEO-cl-PEI /surfactant complexes. Surfactant mole-
charged surfactants is a cooperative process in which cules can bind with the stoichiometric complexes
the ionic head-groups of the surfactant bind to the through interactions with the hydrophobic domains
polyion repeating units while the surfactant alkyl and/or PEO segments of the network.
groups segregate into hydrophobic domains [44]. The binding of anionic surfactants to the amino
Binding of various anionic surfactants with cationic groups of ionic segments of PEO-cl-PEI networks
polyamine segments of PEO-cl-PEI networks was led to a decrease in the particles size to about 50 nm
studied by fluorescence probe (pyrene) technique (compare with the initial size of 300 nm) [45]. A
[45]. This process characterized by a ‘critical as- sharp decrease in the size of the particles was
sociation concentration’ (cac), indicating the onset of observed even under the conditions of the deficiency
surfactant binding to the polyion chains of network. of the surfactant in the reaction mixture (N /S.2.5).
For instance, for sodium tetradecyl sulfate the cac The contraction of PEO-cl-PEI networks as a result
25
value in the presence of PEO-cl-PEI was 3.2 3 10 of surfactant binding was also confirmed by electron
M and was about 2 order of magnitude lower than microscopy. Electron micrographs revealed close to
23the corresponding cmc (2.2 3 10 M), suggesting spherical PEO-cl-PEI particles, which collapsed
that PEO-cl-PEI copolymer promoted the surfactant upon the interaction with amphiphilic molecules.
aggregation. The shift in cac to lower concentrations Based upon the changes of diameters of the particles
compared to the cmc is explained by the cooperative before and after addition of surfactants, as revealed
stabilization of surfactant aggregates as a result of by both light scattering and electron microscopy, the
interaction between surfactant and PEI chains of the volume of the particles decreased more than 100-fold
network. upon interaction of the network with surfactants. A
The complexes of PEO-cl-PEI with surfactants network collapse is typical for polyelectrolyte gels
were characterized by laser microelectrophoresis upon their interaction with oppositely charged sur-
technique and photon correlation spectroscopy at factants [46]. It is noteworthy, however, that despite
various compositions of the mixture [45]. The com- charge neutralization PEO-cl-PEI /surfactant com-
position of the mixture, N /S, is expressed as a ratio plexes formed fine, slightly opalescent dispersions,
of the total concentration of amino groups of PEO- which exhibited no precipitation in the entire ranges
cl-PEI to the concentration of the surfactant in the of N /S and pH examined.
system. In all experiments the concentration of
amino groups (N) was constant while the concen-
tration of the surfactant was varied. Since only a
fraction of amino groups could be protonated at pH 6. Formulations of nanogels with drug
7.0 [42], the stoichiometric compositions of the molecules
mixtures at this pH corresponded to N/S¯2.5. The
net charge of the unloaded PEO-cl-PEI particles was Many biologically active compounds are char-
slightly positive. The small values of the zeta-po- acterized by relatively low solubility, which hinders
tential of these particles are obviously a result of their pharmacological use. At the same time some of
localization of a significant portion of the charged these compounds are ionogenic surfactants that can
amino groups and the condensed counterions within be used as components of block ionomer complexes
the network particles. This should lead to a decrease for drug delivery [47]. Incorporation of amphiphilic
in the electric potential at the surface of shear of molecules with low solubility into PEO-cl-PEI
such particles. Incorporation of surfactant molecules nanogels was evaluated using sodium oleate (OA),
into PEO-cl-PEI resulted in a decrease of zeta-po- indomethacin, and retinoic acid (RA) [45]. In the
tential almost to zero. When an excess of surfactant case of OA and indomethacin the complexes were
was added to the system (N /S,2.5) the net charge prepared by mixing small amounts of concentrated
of the particles became slightly negative. The change solutions of the surfactants in organic solvent (etha-
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nol, dimethylformamide) with aqueous dispersions of can potentially be used for solubilization of hydro-
PEO-cl-PEI (pH 7.0). For both studied compounds phobic drugs.
the fine dispersions of the complex particles were
obtained in the wide range of compositions of the
mixture. These formulations were stable over rela- 7. Formulations of PEO-cl-PEI nanogels with
tively long periods of time (at least a week). How- oligonucleotides
ever, this protocol was not successful in the case of
RA. Mixing of PEO-cl-PEI and RA at pH 7.0 Addition of oligonucleotide to PEO-cl-PEI
resulted in immediate precipitation. Therefore, the nanogel dispersion at pH 7.0 resulted in immediate
complexes were prepared by mixing of the com- formation of polyelectrolyte complexes due to the
ponents at pH 10, under the conditions when RA is binding of oligonucleotide molecules to the PEI
completely ionized and stable (N /S ratio 3.0). This chain fragments of the nanogel [10]. Like in the case
procedure produced a practically transparent and of surfactants discussed above, the properties on the
stable dispersion with the particle size of ca. 70 nm. resulting complexes depended on the ratio of the
After formation at pH 10.0 the pH of dispersion was concentrations of the reacting oppositely charged
adjusted to 7.0. The pH adjustment did not result in a species. In the case of the polynucleotide-based
change of the size of the particles. Furthermore, the complexes the ratio of total nitrogen of PEO-cl-PEI
dispersion remained stable in 0.15 M NaCl. In the to the phosphates of polynucleotide, called ‘N /P
absence of added salt this dispersion could be ratio’ defines the composition of the mixture. The
lyophilized, stored in lyophilized form for several zeta-potential of the PEO-cl-PEI /oligonucleotide
days, and then re-dispersed. This suggested that a complexes was close to zero at N /P ratio 4. Gel
useful pharmaceutical formulation of RA can be permeation HPLC analysis of the oligonucleotide
prepared by its immobilization in the nanogel sys- and PEO-cl-PEI mixtures showed no free oligo-
tem, which is stable at physiological pH and ionic nucleotide in solution at N /P ratios 4 and higher,
strength [45]. suggesting that all oligonucleotide molecules in-
The kinetic of drug release from dispersion of corporated in the nanogel. The PEO-cl-PEI nanogel
nanogel loaded with indomethacin was evaluated loading capacity with respect to the oligonucleotide
21
using the equilibrium dialysis technique [45]. This was 150 mg mg i.e. ca. 15% by weight. At lower
experiment suggested that during the first hour of N /P ratios (i.e. higher oligonucleotide content) free
dialysis over 17.5% of the drug was released in the oligonucleotide was observed in the mixture sug-
external solution. After 24 h ca. 82% of in- gesting that the maximal loading capacity was
domethacin was found in the external solution. The achieved at or about N /P ratio 4. The particle size
release of the drug from PEO-cl-PEI nanogels results decreased upon adding the polynucleotide. In the
in the restoration of the nanogel size. Indeed, the vicinity of the neutralization point at N /P ratio 4, the
estimated effective diameter of the PEO-cl-PEI minimum particle size of ca. 80 nm. was observed.
particles after dialysis was ca. 270 nm. This dem- Nanogel particles revealed the tendency to slowly
onstrates that the biological agents immobilized aggregate at the electroneutrality point. However, no
within the nanogel can be released from it and aggregation was observed at N /P ratio higher than 4
suggests that such systems may be useful for drug when particle exhibited small positive charge.
delivery applications.
The hydrophobic regions of PEO-cl-PEI / surfac-
tant complexes can also serve as non-aqueous reser- 8. Modification of the surface of nanogel
voirs for solubilizing water insoluble molecules. For particles with biospecific ligands
example, PEO-cl-PEI /OA complexes incorporated a
significant amount of water-insoluble dye, Yellow To allow for the targeted delivery of nanogels in
OB [45]. The dye-containing PEO-cl-PEI /OA dis- the body the surface of the nanogel particles can be
persions remained stable for several days. These data modified with various biospecific ligands. Various
suggested that PEO-cl-PEI /surfactant dispersions coupling strategies can be used for this purpose
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including covalent attachment of the ligand moiety to rapidly removed through extravasation and renal
the free amino groups of the PEI fragments in clearance, while larger particles with diameters of
PEO-cl-PEI nanogel. One simple way to introduce more than 10 nm are not removed by these means
various ligands in nanogel particles consists in the [50]. Particles ranging from ca. 10 to 70 nm are still
partial modification of PEI fragments with biotin small enough to penetrate even the very small
moieties [10]. Biotin p-nitrophenyl ester was used capillaries within the body tissues, and therefore may
for modification of amino groups of PEO-cl-PEI. offer the most effective distribution in certain tissues
The amount of biotin moieties conjugated to PEO-cl- [49,51]. For example, particles in this size range are
PEI was determined using analytical assay based on optimal for subcutaneous injection since the particles
the competitive displacement of a fluorescent dye, are more rapidly drained from the injection site [51].
2-anilinonaphthalene-6-sulfonic acid, in the reaction Slightly larger particles, ranging from ca. 70 to 200
with avidin [48]. The biotinylated PEO-cl-PEI nm, demonstrate the most prolonged circulation
nanogel was further reacted with oligonucleotide times [49,53]. In contrast, even larger particles, with
resulting in the formation of the particles, which diameters greater than 200 nm, are usually seques-
were very similar to the ones described in the tered by the spleen as a result of mechanical filtration
previous section. However, the surface of these and are eventually removed by the cells of the
particles also contained the biotin groups, which can phagocyte system [49,52], resulting in decreased
be used for attachment of various vector moieties blood circulation times. This information, combined
(e.g., peptides and antibodies) using standard biotin– with the knowledge that particles which are smaller
avidin coupling chemistry. In the model experiments than 100 nm can be enclosed within endocytic
these particles were coupled with the biotinylated vesicles, allowing entry into target cells via endo-
transferrin and biotinylated insulin through the avidin cytosis [55], leads to the conclusion that the pre-
molecule [10]. The modification technique described ferred size range for drug delivery using nanoscale
in this chapter serves only as one example of particles is from ca. 10 to 100 nm. Therefore, the
possible strategy for targeting nanogels using bio- average hydrodynamic diameters observed for the
specific ligands. Obviously, there could be other loaded PEO-cl-PEI nanogel fit well within the
strategies developed for this purpose including direct preferred size range for drug delivery systems.
conjugation of the ligand with the nanogel. It should
be noted that direct conjugation of a ligand to a
positively charged polymer backbone is associated 10. Uptake of oligonucleotide-loaded nanogel
with concerns regarding changes in the ligand spe- within the cells
cificity. Therefore, a prudent approach for vectoriza-
tion of nanogels might include coupling of a ligand Positively charged nanoscale particles are believed
through a neutral polymer spacer such as coupling of to bind electrostatically with the negatively charged
ligand at the free ends of PEO chains linked to the cell membranes, which is followed by the internali-
nanogel surface. zation of these particles within the cells through the
adsorptive endocytosis [56]. The study of the inter-
nalization of the oligonucleotide-loaded PEO-cl-PEI
9. Effect of the particle size on the biological nanogel suggested that the positively charged par-
properties of drug carriers ticles (N /P ratio 8) are much more efficiently taken
up within the cells than the electroneutral particles
From the drug delivery standpoint, the size of the (N /P ratio 4) [10]. Therefore, to enhance the uptake
particles is particularly important. Size variation of the loaded nanogel particles these particles were
within the nanoscale range will strongly affect both coupled with insulin and transferrin using the biotin–
the blood circulation time as well as the bioavail- avidin coupling technique. As a result a drastic
ability of the particles within the body [49–54]. enhancement of accumulation of the particles within
Typically, following systemic administration, small the cells was observed.
particles with diameters of less than 5–10 nm are Fluorescently tagged oligonucleotides were used
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to examine localization of the oligonucleotides with- of the PEO-cl-PEI /oligonucleotide complexes within
in the cell. Following internalization by endocytosis, the endosomes the cationic PEI chains interact
the major portion of free oligonucleotides is usually electrostatically with negatively charged membrane
sequestered within endosomal and lysosomal com- phospholipids, which locally destabilizes the endo-
partments of the cells [57]. Less significant amounts somal membrane. Furthermore such interaction
of oligonucleotides are also distributed within other should also facilitate the displacement and release of
cellular organelles such as the Golgi complex and the the oligonucleotide from the complex with the
Endoplasmic reticulum [57]. Therefore, addition of nanogel. It is noteworthy that following internaliza-
chloroquine is commonly required to enhance release tion of the PEO-cl-PEI /oligonucleotide complexes
of the oligonucleotide in the cytoplasm and delivery within the cells the nanogel particles are found in the
of the oligonucleotide to the nucleus of the cell [58]. cytoplasmic compartments of the cells, while the
In the case of the oligonucleotides delivered using oligonucleotides accumulate predominantly in the
the PEO-cl-PEI nanogel effective release of the nucleus (unpublished results). The schematic illus-
oligonucleotide and its accumulation within the trating the hypothetical mechanism of the oligo-
nucleus was observed in the absence of chloroquine nucleotide delivery within the cell is presented in
[10]. It is possible that following the internalization Fig. 2. Transport of oligonucleotide delivered with
Fig. 2. (A) Internalization of nanogel /oligonucleotide (ODN) particles by adsorptive mediated endocytosis and putative mechanism of ODN
unloading into the cytosol. (B) Destabilization of the endosomal membrane: (1) interaction of positively charged nanogel particles with
negatively charged phospholipids; (2) nanogel wrapping with interacting phospholipids and (3) collapse of nanogel–phospholipid complex
and relaese of SODN into the cytosol.
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nanogel within the nucleus of the cells is remarkable reaction. Furthermore, the antisense effects were
in view of the well-known difficulties of DNA significantly enhanced when the PEO-cl-PEI /oligo-
delivery to the nucleus of nondividing cells. How- nucleotide complexes were modified with transferrin
ever, small size of oligonucleotide molecule com- using the avidin–biotin coupling technique.
pared to the size of the plasmid DNA might be
beneficial for its nuclear delivery, since oligonucleo-
tide can diffuse through the cytoplasm and penetrate 12. Delivery of oligonucleotides across
the pores in the nuclear membrane. It appears that gastrointestinal epithelium
the oligonucleotide is released within the cell prior to
delivery to the nucleus since relatively large oligo- Oral administration of oligonucleotides would be
nucleotide–nanogel complex cannot cross the nu- advantageous since it offers greater patient com-
clear membrane. Further studies of intracellular pliance. However, oligonucleotides are rapidly de-
trafficking of molecules delivered with nanogels is graded in the gastrointestinal tract and their bioavail-
currently in progress. ability is less than 1% [2]. Poor oral bioavailability
of oligonucleotides is to a significant extent due to
the low efficacy of their transport across gastroin-
11. Biological activity of antisense testinal epithelium [60]. In order to evaluate the
oligonucleotide delivered using nanogel possibility of using PEO-cl-PEI nanogel for oral
administration of oligonucleotides, the permeability
Several recent reports have documented the advan- studies were carried out using polarized Caco-2 cell
tages of polymer particles as effective in vitro and in monolayers and standard Side-Bi-Side two-chamber
vivo delivery systems for antisense oligonucleotides device as an in vitro model of gastrointestinal
[2,59]. Using antisense oligonucleotide directed epithelium [10]. The transfer of the free or nanogel-
against mRNA of membrane P-glycoprotein (Pgp) incorporated oligonucleotide in the receiver chamber
the biological effect of oligonucleotides immobilized was assayed using a fluorescence technique. As is
in the PEO-cl-PEI particles was evaluated in several seen in Fig. 3B, incorporation of the oligonucleotide
multidrug resistant cell lines [10]. This study demon- in nanogel results in a drastic increase in the
strated significant enhancement of antisense inhibi- oligonucleotide transport across the Caco-2 cell
tion of Pgp as a result of incorporation of oligo- monolayers compared to the free oligonucleotide
3
nucleotide in the nanogel as determined using both transport. The transfer of a paracellular marker, H-
Pgp functional assay and the polymerase chain mannitol, in the presence of PEO-cl-PEI /oligonu-
Fig. 3. Permeability of SODN and SODN-loaded nanogel carriers in BBMEC (A) and Caco-2 (B) cell manolayers. SODN concentration in
all experiments was 5 mM. Nanogel particles were loaded at N /P ratio 4 (A) and 8 (B). Concentration of human transferrin and insulin in
the system was 2.5 mM. Quantity of the SODN passed through the cell monolayers was measured by analytical anion exchange HPLC.
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cleotide complexes was not affected, suggesting that enhance current strategies for vector-mediated drug
the observed enhancement of the oligonucleotide delivery to the brain [66].
permeability in Caco-2 cell monolayers is due to the
enhancement in the transcellular delivery route rather
increased leakiness of the cell monolayers. Finally, 14. Conclusions
the analysis of the oligonucleotide in the receiver
chamber using HPLC demonstrated that the oligo- In conclusion, nanogels exemplified in this paper
nucleotide immobilized in nanogel particles crossed using dispersed PEO-cl-PEI networks, appear to be
intestinal cell monolayers without degradation. As a promising and versatile systems for drug delivery.
result of this work, it appears likely that one useful The advantages of these systems include simplicity
application of the nanogel carriers may be in oral of formulation with the drugs, high loading capacity
administration of antisense oligonucleotides. and stability of the resulting formulation in disper-
sion. These systems allow immobilization of bio-
logically active compounds of diverse structure
13. Delivery of oligonucleotides across blood– including charged drugs, low molecular mass hydro-
brain barrier phobes and biopolymers. In addition to the data
presented in this chapter in more recent studies
Brain has recently attracted significant attention as nanogels were used for immobilization of plasmid
a potential target tissue for drug delivery. The DNA and small globular proteins, which will be
sequestered nature of the central nervous system reported separately. Furthermore, nanogels can be
makes delivery of drugs to the brain a challenging chemically modified to incorporate various ligands
task. At present there are few reports of successful for targeted drug delivery. The in vitro studies
delivery of drugs across the blood–brain barrier suggest that nanogels can be used for efficient
(BBB), which involve the use of the block co- delivery of biopharmaceuticals in cells as well as for
polymers, polymer micelles, liposomes and increasing drug delivery across cellular barriers. The
nanoparticles [61–63]. In this respect it was of in vivo evaluation of nanogels is underway.
interest to evaluate the potential of using nanogel
carriers for drug delivery to the brain. The studies
examined delivery of oligonucleotides across the Acknowledgements
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